These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37540484)

  • 41. Readmissions Following Inpatient Treatment for Opioid-Related Conditions.
    Blanchard J; Weiss AJ; Barrett ML; Stocks C; Owens PL; Coffey R; Heslin KC
    Subst Use Misuse; 2019; 54(3):473-481. PubMed ID: 30618327
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Temporal trends in rates of opioid misuse among delivery-related hospitalizations in North Carolina from 2000 to 2014.
    Alemu BT; Beydoun HA; Olayinka O; Young B
    J Addict Dis; 2021; 39(2):270-282. PubMed ID: 33416040
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inpatient Hospital Charge Variability of U.S. Hospitals.
    Park JD; Kim E; Werner RM
    J Gen Intern Med; 2015 Nov; 30(11):1627-32. PubMed ID: 25931006
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pattern and burden of opioid-related hospitalizations in the USA from 2016 to 2018.
    Bedi P; Rai MP; Bumrah K; Singh VK; Arora TK; Singh T
    Br J Clin Pharmacol; 2021 Nov; 87(11):4366-4374. PubMed ID: 33856070
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence and treatment of opioid use disorders among primary care patients in six health systems.
    Lapham G; Boudreau DM; Johnson EA; Bobb JF; Matthews AG; McCormack J; Liu D; Samet JH; Saxon AJ; Campbell CI; Glass JE; Rossom RC; Murphy MT; Binswanger IA; Yarborough BJH; Bradley KA;
    Drug Alcohol Depend; 2020 Feb; 207():107732. PubMed ID: 31835068
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Opioid use disorder in the United States: insurance status and treatment access.
    Becker WC; Fiellin DA; Merrill JO; Schulman B; Finkelstein R; Olsen Y; Busch SH
    Drug Alcohol Depend; 2008 Apr; 94(1-3):207-13. PubMed ID: 18222051
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical impact, costs, and cost-effectiveness of hospital-based strategies for addressing the US opioid epidemic: a modelling study.
    Barocas JA; Savinkina A; Adams J; Jawa R; Weinstein ZM; Samet JH; Linas BP
    Lancet Public Health; 2022 Jan; 7(1):e56-e64. PubMed ID: 34861189
    [TBL] [Abstract][Full Text] [Related]  

  • 48. U.S. National 90-Day Readmissions After Opioid Overdose Discharge.
    Peterson C; Liu Y; Xu L; Nataraj N; Zhang K; Mikosz CA
    Am J Prev Med; 2019 Jun; 56(6):875-881. PubMed ID: 31003811
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comprehensive multivariate model of biopsychosocial factors associated with opioid misuse and use disorder in a 2017-2018 United States national survey.
    Montiel Ishino FA; McNab PR; Gilreath T; Salmeron B; Williams F
    BMC Public Health; 2020 Nov; 20(1):1740. PubMed ID: 33208132
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Utilization due to chronic obstructive pulmonary disease and its predictors: a study using the U.S. National Emergency Department Sample (NEDS).
    Singh JA; Yu S
    Respir Res; 2016 Jan; 17():1. PubMed ID: 26739476
    [TBL] [Abstract][Full Text] [Related]  

  • 51. U.S. county prevalence of retail prescription opioid sales and opioid-related hospitalizations from 2011 to 2014.
    Ghertner R
    Drug Alcohol Depend; 2019 Jan; 194():330-335. PubMed ID: 30472572
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patient and Hospital Characteristics of Newborns with Neonatal Withdrawal Syndrome.
    Alemu BT; Olayinka O; Young B; Pressley-Byrd D; Tate T; Beydoun HA
    South Med J; 2020 Aug; 113(8):392-398. PubMed ID: 32747968
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Post-Discharge Treatment Engagement Among Patients with an Opioid-Use Disorder.
    Naeger S; Mutter R; Ali MM; Mark T; Hughey L
    J Subst Abuse Treat; 2016 Oct; 69():64-71. PubMed ID: 27568512
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inpatient Palliative Care Is Less Utilized in Rare, Fatal Extrahepatic Cholangiocarcinoma: A Ten-Year National Perspective.
    Mojtahedi Z; Yoo JW; Callahan K; Bhandari N; Lou D; Ghodsi K; Shen JJ
    Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639305
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of Opioid-Related Adverse Drug Events With Clinical and Cost Outcomes Among Surgical Patients in a Large Integrated Health Care Delivery System.
    Shafi S; Collinsworth AW; Copeland LA; Ogola GO; Qiu T; Kouznetsova M; Liao IC; Mears N; Pham AT; Wan GJ; Masica AL
    JAMA Surg; 2018 Aug; 153(8):757-763. PubMed ID: 29799927
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pediatric acquired demyelinating syndrome (ADS) in inpatient hospital settings: The hospitalization rate, costs, and outcomes in the US.
    Minegishi M; Takahashi T; Testa M
    Mult Scler Relat Disord; 2019 Sep; 34():150-157. PubMed ID: 31295724
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Documented opioid use disorder and its treatment in primary care patients across six U.S. health systems.
    Boudreau DM; Lapham G; Johnson EA; Bobb JF; Matthews AG; McCormack J; Liu D; Campbell CI; Rossom RC; Binswanger IA; Yarborough BJ; Arnsten JH; Cunningham CO; Glass JE; Murphy MT; Zare M; Hechter RC; Ahmedani B; Braciszewski JM; Horigian VE; Szapocznik J; Samet JH; Saxon AJ; Schwartz RP; Bradley KA
    J Subst Abuse Treat; 2020 Mar; 112S():41-48. PubMed ID: 32220410
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Estimates of charges associated with emergency department and hospital inpatient care for opioid abuse-related events.
    Chandwani HS; Strassels SA; Rascati KL; Lawson KA; Wilson JP
    J Pain Palliat Care Pharmacother; 2013 Aug; 27(3):206-13. PubMed ID: 23879214
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Time-trends in hospitalizations with cannabis use disorder: A 17-year U.S. national study.
    Singh JA
    Subst Abus; 2022; 43(1):408-414. PubMed ID: 34214395
    [No Abstract]   [Full Text] [Related]  

  • 60. Chronic non-cancer pain among adults with substance use disorders: Prevalence, characteristics, and association with opioid overdose and healthcare utilization.
    John WS; Wu LT
    Drug Alcohol Depend; 2020 Apr; 209():107902. PubMed ID: 32088587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.